← Open Payments lookup

JENNIFER GRAHAM: Open Payments

NPI 1972796944 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$556 in 28 payments from 11 companies in 2025. Trend: 2023 $796 · 2024 $733 · 2025 $556

Food & beverage: $556
CompanyPaymentsAmount
ABBVIE INC.12$196
Astellas Pharma US Inc4$131
Novo Nordisk Inc3$59
Otsuka America Pharmaceutical, Inc.2$45
Janssen Pharmaceuticals, Inc1$25
Janssen Biotech, Inc.1$20
Organon LLC1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16
Boehringer Ingelheim Pharmaceuticals, Inc.1$14
E.R. Squibb & Sons, L.L.C.1$14

Products named: Veozah, VRAYLAR, UBRELVY, QULIPTA, REXULTI, Ozempic, SPRAVATO, Rybelsus.

Industry payments across NE — which companies pay providers there.